June 2024 - PharmaTimes

Published on 23 May 2024

Description:

This issue is about the shaping, delivery and future of clinical trials – the exciting dawn of a new era for how therapies reach the marketplace. We cover the influence of digital, the radical shift in trial design and, above all, the need to incorporate patients at every stage. We’ve also got a review of our International Clinical Researcher of the Year bash – an unforgettable 25th edition of the enduring event. In addition, this issue looks at the influence of Florence Nightingale as an ace healthcare communicator, the future of unlicenced meds and the emerging involvement of AI across the life sciences.

Categories:

PharmaTimes

Preview:

29 articles from this collection:

June 24 - Cover

2 - Advertisements

From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration. A

4-5 - Contents

NEWS: Treatments

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.

NEWS: Research

NEWS: Collaborations

NEWS: Conditions

COVER STORY - The trials of our lives

YOUNG LEADERS: New age

13 - LAMBERT SMITH HAMPTON

CLINICAL TRIALS: Pump up the volume

CLINICAL TRIALS - Rare disease clinical trials

ASTRAZENECA

Happy anniversary!

PHARMA: Maximising success through strategic partnerships

PATIENTS: The ‘activated’ patient conundrum

23 - CLINICAL TRIALS: Time trials

BOBI AWARDS 2024: Totally triumphant!

WOMEN IN PHARMA: One direction

COMMUNICATIONS: Old schooled

MEDICINES - Can’t give it a label?

CLINICAL TRIALS: Pictures of you

MARKETING: Talking heads

PATIENTS: Knowing me, knowing you

36-37 - Your moves

CLINICAL TRIALS – Crunch time

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com

https://pharmatimes.com/